Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 13, 2022

Total Value: $489M (100.0% shares, 0.0% debt)

Holdings (22)

NUVB Nuvation Bio 24.7%

Value $121M Shares 22,957,340 Est. Cost $11.18 Unrealized -49.8%

REPL Replimune Group 16.2%

Value $79.35M Shares 4,673,380 Est. Cost $17.40 Unrealized +8.4%

— Imago Biosciences 11.9%

Value $58.17M Shares 3,018,737 Est. Cost $20.03 Unrealized —

— Morphic Holding 9.9%

Value $48.18M Shares 1,200,014 Est. Cost $19.82 Unrealized —

— Kronos Bio 5.6%

Value $27.61M Shares 3,818,283 Est. Cost $29.87 Unrealized —

GOSS Gossamer Bio 5.6%

Value $27.47M Shares 3,164,835 Est. Cost $20.85 Unrealized -53.8%

IMUX Immunic Inc 4.1%

Value $20.21M Shares 1,788,160 Est. Cost $13.89 Unrealized -16.7%

— Alpine Immune Sciences 3.7%

Value $18.2M Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Cincor 3.5%

Value $16.95M Shares 966,176 Est. Cost $17.54 Unrealized —

— Ikena Oncology 2.8%

Value $13.72M Shares 2,249,123 Est. Cost $28.25 Unrealized —

ARQT Arcutis Biothereapeutics 2.5%

Value $12.02M Shares 623,836 Est. Cost $26.87 Unrealized -37.0%

— Theseus Pharmaceuticals 1.7%

Value $8.203M Shares 711,479 Est. Cost $12.68 Unrealized —

SANA Sana Biotechnology, Inc. 1.4%

Value $6.969M Shares 843,750 Est. Cost $32.56 Unrealized -75.2%

— Paratek Pharmaceuticals 1.2%

Value $5.855M Shares 1,971,241 Est. Cost $34.18 Unrealized —

— Omega Alpha SPAC 1.0%

Value $4.92M Shares 501,000 Est. Cost $9.98 Unrealized —

— Spruce Biosciences 0.9%

Value $4.344M Shares 2,161,022 Est. Cost $24.31 Unrealized —

— Checkmate Pharmaceuticals 0.9%

Value $4.259M Shares 1,335,050 Est. Cost $11.51 Unrealized —

— Icosavax 0.6%

Value $3.002M Shares 426,395 Est. Cost $29.59 Unrealized —

— Syros Pharmaceuticals 0.6%

Value $2.99M Shares 2,512,705 Est. Cost $8.72 Unrealized —

— ESSA Pharma 0.4%

Value $2.028M Shares 328,196 Est. Cost $3.14 Unrealized —

— Jounce Therapeutics 0.4%

Value $1.871M Shares 275,513 Est. Cost $21.99 Unrealized —

IMCR Immunocore Holdings 0.3%

Value $1.541M Shares 51,535 Est. Cost $42.57 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	22,957,340	$121M	24.7%	$11.18	-49.8%	Class A Common Stock	67080N101
REPL	Replimune Group	4,673,380	$79.35M	16.2%	$17.40	+8.4%	Common Stock	76029N106
—	Imago Biosciences	3,018,737	$58.17M	11.9%	$20.03	—	Common Stock	45250K107
—	Morphic Holding	1,200,014	$48.18M	9.9%	$19.82	—	Common Stock	61775R105
—	Kronos Bio	3,818,283	$27.61M	5.6%	$29.87	—	Common Stock	50107A104
GOSS	Gossamer Bio	3,164,835	$27.47M	5.6%	$20.85	-53.8%	Common Stock	38341P102
IMUX	Immunic Inc	1,788,160	$20.21M	4.1%	$13.89	-16.7%	Common Stock	4525EP101
—	Alpine Immune Sciences	2,029,580	$18.2M	3.7%	$9.48	—	Common Stock	02083G100
—	Cincor	966,176	$16.95M	3.5%	$17.54	—	Common Stock	17240Y109
—	Ikena Oncology	2,249,123	$13.72M	2.8%	$28.25	—	Common Stock	45175G108
ARQT	Arcutis Biothereapeutics	623,836	$12.02M	2.5%	$26.87	-37.0%	Common Stock	03969K108
—	Theseus Pharmaceuticals	711,479	$8.203M	1.7%	$12.68	—	Common Stock	88369M101
SANA	Sana Biotechnology, Inc.	843,750	$6.969M	1.4%	$32.56	-75.2%	Common Stock	799566104
—	Paratek Pharmaceuticals	1,971,241	$5.855M	1.2%	$34.18	—	Common Stock	699374302
—	Omega Alpha SPAC	501,000	$4.92M	1.0%	$9.98	—	Class A Common Stock	G6749V107
—	Spruce Biosciences	2,161,022	$4.344M	0.9%	$24.31	—	Common Stock	85209E109
—	Checkmate Pharmaceuticals	1,335,050	$4.259M	0.9%	$11.51	—	Common Stock	162818108
—	Icosavax	426,395	$3.002M	0.6%	$29.59	—	Common Stock	45114M109
—	Syros Pharmaceuticals	2,512,705	$2.99M	0.6%	$8.72	—	Common Stock	87184Q107
—	ESSA Pharma	328,196	$2.028M	0.4%	$3.14	—	Common Stock	29668H708
—	Jounce Therapeutics	275,513	$1.871M	0.4%	$21.99	—	Common Stock	481116101
IMCR	Immunocore Holdings	51,535	$1.541M	0.3%	$42.57	—	Common Stock	45258D105